• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Lottery.com Shares Are Trading Lower By 59%? 54 Stocks Moving In Friday's Mid-Day Session

    7/29/22 1:05:50 PM ET
    $AMTX
    $AMZN
    $ATHX
    $AVTR
    Major Chemicals
    Industrials
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $AMTX alert in real time by email

    Gainers

    • Getty Images Holdings, Inc. (NYSE:GETY) shares jumped 106.7% to $21.69 after nearly 99.4% of shares were redeemed by CCNB shareholders.
    • NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) rose 91.1% to $1.00. The U.S. Food and Drug Administration (FDA) recently declined to issue an Emergency Use Authorization (EUA) for NRx Pharmaceuticals’ lead drug ZYESAMI (aviptadil) for subgroup of patients with critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir.
    • ThermoGenesis Holdings, Inc. (NASDAQ:THMO) rose 29.7% to $0.2752 after gaining over 6% on Thursday.
    • Ayala Pharmaceuticals, Inc. (NASDAQ:AYLA) jumped 29.4% to $1.85. Ayala Pharmaceuticals recently filed a request for the withdrawal of the Registration Statement on Form S-1.
    • SAI.TECH Global Corporation (NASDAQ:SAI) surged 26.9% to $6.84.
    • GeoVax Labs, Inc. (NASDAQ:GOVX) jumped 24.1% to $2.4699. GeoVax Labs announced the publication of a peer-reviewed animal efficacy study of its modified vaccine Ankara vectored vaccine against Sudan ebolavirus.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) gained 22.4% to $7.18. The company entered into an agreement with Ace Hardware USA to sell 35 products across 5,500 stores.
    • AXT, Inc. (NASDAQ:AXTI) shares gained 21.7% to $8.55 after the company reported better-than-expected Q2 EPS.
    • U.S. Silica Holdings, Inc. (NYSE:SLCA) climbed 21.7% to $14.89 after the company reported better-than-expected Q2 EPS and sales results.
    • Q&K International Group Limited (NASDAQ:QK) rose 21.4% to $2.27.
    • Mitek Systems, Inc. (NASDAQ:MITK) gained 21.1% to $10.93 after the company reported better-than-expected Q3 results.
    • Rockley Photonics Holdings Limited (NYSE:RKLY) rose 19.1% to $2.81.
    • Aemetis, Inc. (NASDAQ:AMTX) gained 18.5% to $7.57.
    • Centogene N.V. (NASDAQ:CNTG) jumped 17.5% to $1.68.
    • Xilio Therapeutics, Inc. (NASDAQ:XLO) rose 17.3% to $3.1899.
    • Data I/O Corporation (NASDAQ:DAIO) gained 17% to $3.5922 following strong Q2 results.
    • World Fuel Services Corporation (NYSE:INT) surged 16% to $26.99 after the company reported better-than-expected Q2 adjusted EPS and sales results.
    • CVRx, Inc. (NASDAQ:CVRX) gained 15.8% to $8.74 after the company reported better-than-expected Q2 sales results.
    • Senti Biosciences, Inc. (NASDAQ:SNTI) rose 15.5% to $2.15 after declining 5% on Thursday.
    • Dawson Geophysical Company (NASDAQ:DWSN) surged 15.5% to $1.79.
    • Omeros Corporation (NASDAQ:OMER) gained 15% to $5.14 after the FDA granted Orphan Drug Designation to OMS906 for the treatment of paroxysmal nocturnal hemoglobinuria.
    • Houston American Energy Corp. (NYSE:HUSA) jumped 14.1% to $4.7016.
    • Rite Aid Corporation (NYSE:RAD) gained 14% to $8.70. Traders circulated Dealreporter chatter that activists might be eyeing the company.
    • Mammoth Energy Services, Inc. (NASDAQ:TUSK) rose 13.8% to $2.72 after the company reported better-than-expected Q2 sales results and EPS results were higher year over year.
    • Graham Corporation (NYSE:GHM) jumped 13.7% to $7.51 after the company reported better-than-expected Q1 adjusted EPS and sales results.
    • Resources Connection, Inc. (NASDAQ:RGP) gained 13.3% to $22.94 following upbeat Q4 earnings.
    • Haynes International, Inc. (NASDAQ:HAYN) gained 12.8% to $38.90 after the company reported better-than-expected Q3 results.
    • DAVIDsTEA Inc. (NASDAQ:DTEA) climbed 12.6% to $1.52.
    • Amazon.com, Inc. (NASDAQ:AMZN) rose 12.2% to $137.20 after the company reported better-than-expected results for its second quarter. The company said it expects-third quarter net sales to be in a range of $125 billion to $130 billion, up 13% to 17% year-over-year.
    • Five9, Inc. (NASDAQ:FIVN) gained 12.2% to $110.42 after the company reported better-than-expected Q2 results and issued strong guidance.
    • Deckers Outdoor Corporation (NYSE:DECK) jumped 9.4% to $314.50 after the company reported better-than-expected Q1 EPS and sales results.
    • Transocean Ltd. (NYSE:RIG) gained 9.1% to $3.2850.
    • Chevron Corporation (NYSE:CVX) rose 8.5% to $163.21 after the company reported better-than-expected Q2 EPS and sales results.
    • CHW Acquisition Corporation (NASDAQ:CHWA) rose 7% to $9.90. CHW Acquisition’s stockholders approved proposed merger transaction with Wag Labs, Inc.
    • Chart Industries, Inc. (NYSE:GTLS) gained 6.7% to $191.12 following Q2 earnings.
    • Apple Inc. (NASDAQ:APPL) rose 3.9% to $163.50 as the company reported better-than-expected results for its fiscal year third-quarter, helped by strong iPhone and iPad sales.


    Losers

    • Lottery.com Inc. (NASDAQ:LTRY) shares tumbled 59% to $0.3342 after the company in an SEC filing said its board determined it does not have sufficient financial resources to fund operations.
    • Avaya Holdings Corp. (NASDAQ:AVYA) shares dipped 51.4% to $1.0150 after the company cut Q3 revenue guidance. Craig-Hallum downgraded Avaya from Buy to Hold.
    • Holley Inc. (NYSE:HLLY) fell 32% to $8.60 after the company lowered its FY22 sales guidance below analyst estimates.
    • Nutriband Inc. (NASDAQ:NTRB) fell 29.2% to $5.50.
    • Roku, Inc. (NASDAQ:ROKU) shares fell 25.2% to $63.75 after the company reported weaker-than-expected financial results for its second quarter and withdrew its full-year revenue growth guidance. Roku said it expects third-quarter revenue to increase about 3% year-over-year to $700 million.
    • Missfresh Limited (NASDAQ:MF) shares fell 13.3% to $0.1172 after the company adopted significant business strategy adjustments. The company received RMB200 million equity investment pursuant to investment agreement and highlighted temporary shutdown of on-demand distributed mini warehouse.
    • SKYX Platforms Corp. (NASDAQ:SKYX) fell 13% to $6.12. Benchmark, on Thursday, initiated coverage on the stock with a Buy rating and announced a $15 price target.
    • VolitionRx Limited (NYSE:VNRX) fell 12.4% to $1.9964 after the company reported pricing of $6 million underwritten public offering of common stock.
    • Athersys, Inc. (NASDAQ:ATHX) dipped 12.4% to $0.2846.
    • Nutex Health, Inc. (NASDAQ:NUTX) fell 12.2% to $2.6590.
    • ObsEva SA (NASDAQ:OBSV) fell 12.2% to $0.2651 as the company reported the resignation of Jean-Pierre Gotteland, Chief Scientific Officer and Head of Research & Development, effective September 30, 2022.
    • Cryptyde, Inc. (NASDAQ:TYDE) dropped 11.8% to $1.19.
    • Avantor, Inc. (NYSE:AVTR) shares fell 11.4% to $28.60 after the company reported worse-than-expected Q2 EPS and sales results.
    • QualTek Services Inc. (NASDAQ:QTEK) dipped 10.9% to $1.1850.
    • China Natural Resources, Inc. (NASDAQ:CHNR) fell 10.3% to $0.6013.
    • Intel Corporation (NASDAQ:INTC) fell 10.2% to $35.67 after the company reported worse-than-expected Q2 EPS and sales results. The company also issued Q3 and FY22 EPS and sales guidance below analyst estimates.
    • Bausch Health Companies Inc. (NYSE:BHC) dipped 8.9% to $4.6430 after several analysts downgraded the stock amid concerns. The stock has fallen over the past two sessions amid an expected court decision in the XIFAXAN patent litigation.
    • DexCom, Inc. (NASDAQ:DXCM) fell 5.4% to $82.29 after the company reported worse-than-expected Q2 EPS and sales results.
    Get the next $AMTX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMTX
    $AMZN
    $ATHX
    $AVTR

    CompanyDatePrice TargetRatingAnalyst
    Avantor Inc.
    $AVTR
    3/6/2026$8.50Equal Weight → Underweight
    Barclays
    SKYX Platforms Corp.
    $SKYX
    3/5/2026$5.00Buy
    Lake Street
    Amazon.com Inc.
    $AMZN
    2/23/2026$305.00 → $304.00Overweight
    Wells Fargo
    Deckers Outdoor Corporation
    $DECK
    2/20/2026Hold → Buy
    Argus
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    Transocean Ltd (Switzerland)
    $RIG
    2/18/2026$6.00Overweight → Equal Weight
    Barclays
    Chevron Corporation
    $CVX
    2/17/2026$205.00Hold → Buy
    Melius
    Intel Corporation
    $INTC
    2/13/2026$45.00Neutral
    DA Davidson
    More analyst ratings

    $AMTX
    $AMZN
    $ATHX
    $AVTR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 11, 2025 - FDA Roundup: March 11, 2025

    For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    November 14, 2023 - FDA Roundup: November 14, 2023

    For Immediate Release: November 14, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA updated the advisory for the Investigation of Elevated Lead Levels in Cinnamon Applesauce Pouches to include an expanded recall from WanaBana LLC to include Weis and Schnucks-brand cinnamon applesauce pouches. As of November 13, 2023, there

    11/14/23 3:26:18 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMTX
    $AMZN
    $ATHX
    $AVTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Avantor downgraded by Barclays with a new price target

    Barclays downgraded Avantor from Equal Weight to Underweight and set a new price target of $8.50

    3/6/26 8:24:43 AM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Lake Street initiated coverage on SKYX Platforms with a new price target

    Lake Street initiated coverage of SKYX Platforms with a rating of Buy and set a new price target of $5.00

    3/5/26 8:12:08 AM ET
    $SKYX
    Building Products
    Consumer Discretionary

    Wells Fargo reiterated coverage on Amazon with a new price target

    Wells Fargo reiterated coverage of Amazon with a rating of Overweight and set a new price target of $304.00 from $305.00 previously

    2/23/26 10:45:11 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMTX
    $AMZN
    $ATHX
    $AVTR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lucier Gregory T bought $458,000 worth of shares (50,000 units at $9.16) (SEC Form 4)

    4 - Avantor, Inc. (0001722482) (Issuer)

    2/23/26 8:53:53 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Jain Mudit K. bought $297,592 worth of shares (46,800 units at $6.36) (SEC Form 4)

    4 - CVRx, Inc. (0001235912) (Issuer)

    2/23/26 6:00:12 AM ET
    $CVRX
    Medical/Dental Instruments
    Health Care

    Director Jain Mudit K. bought $2,785 worth of shares (600 units at $4.64), increasing direct ownership by 12% to 5,650 units (SEC Form 4)

    4 - CVRx, Inc. (0001235912) (Issuer)

    2/18/26 5:22:25 PM ET
    $CVRX
    Medical/Dental Instruments
    Health Care

    $AMTX
    $AMZN
    $ATHX
    $AVTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    UGG Leans Into Fashion & Function for Spring 2026 Sneaker Offering

    Brand Reinvents Classic Styles for Everyday Wear & Warmer Weather Southern California-based global lifestyle brand UGG® (a division of Deckers Brands (NYSE: DECK) introduces an offering of sneakers that preserves the brand's iconic heritage while incorporating enhanced utility capabilities. Meet the new Heritage Utility collection. Classic meets modern, rugged yet refined, day to night. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312916166/en/UGG Heritage Utility Axoid Rooted in reinvention, the men's design evolution, and the brand's DNA of comfort crafted to last, UGG® explores how to elevate its classic core silhouett

    3/12/26 9:00:00 AM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    RGP Elevates Elon Friedman to Lead Tax and Treasury Consulting Practice

    RGP (NASDAQ:RGP), a global professional services firm, today announced that Elon Friedman will lead its Tax and Treasury Consulting Practice. The appointment underscores RGP's continued investment in high-impact finance capabilities that support CFOs as they navigate regulatory complexity, capital allocation strategy, and enterprise-wide transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312959825/en/Elon Friedman, Tax and Treasury Consulting Practice Leader at RGP As finance leaders face increasing pressure to preserve liquidity, optimize working capital, and manage risk, tax and treasury have become central to e

    3/12/26 9:00:00 AM ET
    $RGP
    Real Estate

    Elsa Hosk & Rina Sawayama Celebrate Signature Feel of UGG With New Spring Styles

    Same Cozy Feeling, Same UGG, All-Year Long Southern California-based global lifestyle brand UGG® (a division of Deckers Brands (NYSE: DECK) reimagines its iconic classics into new, dynamic, warm-weather styles. Introducing the Spring 2026 Golden Collection, a line of sandals and clogs that deliver the UGG signature comfort and style for sunny days. The same cozy feeling, the same UGG®, all year long. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312503059/en/Elsa Hosk Wearing The GoldenGlow Embossed Fall 2025 campaign stars Elsa Hosk and Rina Sawayama return this Spring to tell the story of how the well-loved Classic Boot

    3/12/26 9:00:00 AM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    $AMTX
    $AMZN
    $ATHX
    $AVTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Nutex Health Inc.

    4 - Nutex Health Inc. (0001479681) (Issuer)

    3/11/26 6:27:50 PM ET
    $NUTX
    Real Estate

    SEC Form 4 filed by Nutex Health Inc.

    4 - Nutex Health Inc. (0001479681) (Issuer)

    3/11/26 6:08:03 PM ET
    $NUTX
    Real Estate

    SEC Form 4 filed by Nutex Health Inc.

    4 - Nutex Health Inc. (0001479681) (Issuer)

    3/11/26 5:52:21 PM ET
    $NUTX
    Real Estate

    $AMTX
    $AMZN
    $ATHX
    $AVTR
    SEC Filings

    View All

    Xilio Therapeutics Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Xilio Therapeutics, Inc. (0001840233) (Filer)

    3/12/26 8:34:51 AM ET
    $XLO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aemetis Inc. (DE) filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - AEMETIS, INC (0000738214) (Filer)

    3/12/26 8:30:09 AM ET
    $AMTX
    Major Chemicals
    Industrials

    SEC Form FWP filed by Amazon.com Inc.

    FWP - AMAZON COM INC (0001018724) (Subject)

    3/11/26 4:11:57 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMTX
    $AMZN
    $ATHX
    $AVTR
    Leadership Updates

    Live Leadership Updates

    View All

    RGP Appoints Jennifer Garcia as Finance Transformation Practice Leader to Accelerate CFO-Led Enterprise Modernization

    RGP (NASDAQ:RGP), a global professional services firm, today announced the promotion of Jennifer Garcia to Finance Transformation Practice Leader. The move underscores RGP's continued investment in finance transformation as a cornerstone of its consulting strategy, supporting CFOs and CIOs as they modernize operating models, unlock AI-enabled insight, and drive enterprise value creation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311897305/en/Jennifer Garcia, Finance Transformation Practice Leader at RGP As market volatility, M&A acceleration, enterprise resource planning (ERP) modernization, and AI adoption reshape the e

    3/11/26 9:00:00 AM ET
    $RGP
    Real Estate

    RGP Appoints Daniel Boyer as Head of M&A to Accelerate CFO and CIO-Led Enterprise Transformation

    RGP (NASDAQ:RGP), a global professional services firm, today announced the appointment of Daniel Boyer as Senior Vice President, Head of M&A. The appointment underscores RGP's continued investment in high-growth, cross-domain solution areas that unite CFO Advisory and CIO Solutions to support enterprise leaders navigating complex transactions and accelerating transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310756045/en/Daniel Boyer, Senior Vice President, Head of M&A at RGP In this newly established role, Boyer will lead the expansion of RGP's M&A offering across the full transaction lifecycle, from financial a

    3/10/26 9:00:00 AM ET
    $RGP
    Real Estate

    RGP Names Stephen Hook as Digital Solutions Leader, Strengthening Enterprise Technology and AI Capabilities

    RGP (NASDAQ:RGP), a global professional services firm, today announced the appointment of Stephen Hook as Digital Solutions Leader as part of the expansion of the firm's Consulting Segment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305232232/en/Stephen Hook, Digital Solutions Leader at RGP The appointment reflects RGP's continued investment in scalable, outcome-driven consulting and reinforces the firm's commitment to integrating finance and technology as the dual engines of enterprise transformation. It aligns with the evolving priorities of CFOs, CIOs, and enterprise leaders as they navigate ERP modernization, AI and d

    3/5/26 9:00:00 AM ET
    $RGP
    Real Estate

    $AMTX
    $AMZN
    $ATHX
    $AVTR
    Financials

    Live finance-specific insights

    View All

    Aemetis Reports Fourth Quarter and Full Year 2025 Results as Dairy RNG Platform Scales

    Dairy RNG production increased 61% year over year in Q4 2025; ethanol plant efficiency upgrade expected to increase plant cash flow from operations by approximately $32 million annually Aemetis Biogas segment net income increased to $12.2 million in Q4 2025Aemetis Biogas segment increased annual revenues and production tax credits by 53%Dairy RNG production increased 61% year over year in Q4 2025Aemetis Biogas achieved annual segment net income of $6.9 millionCapital investments increased 28% over the prior year to $26.0 million, supporting dairy RNG expansion and ethanol plant energy efficiency upgradesDairy digester projects generated cash proceeds of $18 million during 2025 from the sale

    3/12/26 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Mammoth Energy Services, Inc. Announces Fourth Quarter and Full Year 2025 Operational and Financial Results

    OKLAHOMA CITY, March 6, 2026 /PRNewswire/ -- Mammoth Energy Services, Inc. (NASDAQ:TUSK) ("Mammoth" or the "Company") today reported financial and operational results for the fourth quarter and full year ended  Mark Layton, Chief Financial Officer of Mammoth commented, "2025 was a transformative year for Mammoth. We made the deliberate decision to reshape our portfolio, with four divestitures generating in excess of $150 million in cash proceeds. These transactions strengthened our balance sheet, pruned non-performing businesses and gave us the financial flexibility to invest in higher-return opportunities. Most notably, we deployed over $65 million into our aviation platform at an attractiv

    3/6/26 8:00:00 AM ET
    $TUSK
    Oilfield Services/Equipment
    Energy

    Aemetis to Review Fourth Quarter and Year End 2025 Financial Results on March 12, 2026

    CUPERTINO, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ:AMTX) announced that the company will host a conference call to review the release of its fourth quarter and year end 2025 earnings report: Date: Thursday, March 12, 2026 Time: 11 am Pacific Time (PT) Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 452750 Live Participant Dial In (International): +1-973-528-0011 entry code 452750 Webcast URL: https://www.webcaster4.com/Webcast/Page/2211/53629 Attendees may submit questions during the Q&A (Questions & Answers) portion of the conference call. The webcast will be available on the Company's website (www.aemetis.com) under Investors/Conference Cal

    3/6/26 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    $AMZN
    $ATHX
    $AVTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Senti Biosciences Inc.

    SC 13D/A - Senti Biosciences, Inc. (0001854270) (Subject)

    12/4/24 7:08:03 PM ET
    $SNTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Getty Images Holdings Inc.

    SC 13D/A - Getty Images Holdings, Inc. (0001898496) (Subject)

    11/22/24 5:10:10 PM ET
    $GETY
    Real Estate

    Amendment: SEC Form SC 13D/A filed by SKYX Platforms Corp.

    SC 13D/A - SKYX Platforms Corp. (0001598981) (Subject)

    11/22/24 5:00:10 PM ET
    $SKYX
    Building Products
    Consumer Discretionary